Literature DB >> 7532241

Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association.

P A Singer1, D S Cooper, E G Levy, P W Ladenson, L E Braverman, G Daniels, F S Greenspan, I R McDougall, T F Nikolai.   

Abstract

OBJECTIVE: To develop a set of minimum clinical guidelines for use by primary care physicians in the evaluation and management of patients with hyperthyroidism and hypothyroidism. PARTICIPANTS: Guidelines were developed by a nine-member ad hoc Standards of Care Committee of the American Thyroid Association (the authors of this article). The participants were selected by the committee chair and the president of the American Thyroid Association on the basis of their clinical experience. The committee members represented different geographic areas within the United States, in order to take into account different practice styles. EVIDENCE: Guidelines were developed on the basis of expert opinion of the participants, as well as on available published information. CONSENSUS PROCESS: Input was obtained from all of the participants, each of whom wrote an initial section of the document. A complete draft document was then written by three participants (P.A.S., D.S.C., and E.G.L.) and resubmitted to the entire committee for revision. The revised document was then submitted to the entire membership of the American Thyroid Association for written comments, which were then reviewed (mainly by P.A.S., D.S.C., and E.G.L.). Many of the suggestions of the American Thyroid Association members were incorporated into the final draft, which was then approved by the Executive Council of the American Thyroid Association. The entire process, from initial drafts to final approval, took approximately 18 months.
CONCLUSIONS: A set of minimum clinical guidelines for the diagnosis and treatment of hyperthyroidism and hypothyroidism were developed by consensus of a group of experienced thyroidologists. The guidelines are intended to be used by physicians in their care of patients with thyroid disorders, with the expectation that more effective care can be provided, and at a cost savings.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532241

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  61 in total

1.  Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years.

Authors:  F Escobar-Jiménez; M L Férnandez-Soto; V Luna-López; M Quesada-Charneco; D Glinoer
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

2.  Occupational pesticide exposure and subclinical hypothyroidism among male pesticide applicators.

Authors:  Catherine C Lerro; Laura E Beane Freeman; Curt T DellaValle; Muhammad G Kibriya; Briseis Aschebrook-Kilfoy; Farzana Jasmine; Stella Koutros; Christine G Parks; Dale P Sandler; Michael C R Alavanja; Jonathan N Hofmann; Mary H Ward
Journal:  Occup Environ Med       Date:  2017-08-03       Impact factor: 4.402

3.  Long-term immunological study in Graves' disease treated with thyroid arterial embolization.

Authors:  Wei Zhao; Bu-Lang Gao; Cang-Zheng Jin; Gen-Fa Yi; Hui-Ying Yang; Hong Li; Dian-Ping Song; Ji-Hong Hu; Yong-Neng Jiang
Journal:  J Clin Immunol       Date:  2008-07-17       Impact factor: 8.317

4.  Comment on long-term risk in radioiodine treatment of hyperthyroidism.

Authors:  Agata Baldys-Waligorska; Alicja Hubalewska-Dydejczyk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09       Impact factor: 9.236

5.  Oxidative stress in patients with thyroidectomy and thyroparathyroidectomy under replacement therapy.

Authors:  Murat Kaçmaz; Murat Atmaca; Ayşe Arslan; Halit Demir; Mehmet Fatih Özbay
Journal:  Endocrine       Date:  2014-04-24       Impact factor: 3.633

Review 6.  Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology.

Authors:  M P Vanderpump; J A Ahlquist; J A Franklyn; R N Clayton
Journal:  BMJ       Date:  1996-08-31

7.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

8.  COPD and thyroid dysfunctions.

Authors:  Claudio Terzano; S Romani; G Paone; V Conti; F Oriolo
Journal:  Lung       Date:  2013-11-27       Impact factor: 2.584

9.  Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.

Authors:  R Ebner; M H Devoto; D Weil; M Bordaberry; C Mir; H Martinez; L Bonelli; H Niepomniszcze
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

10.  New insights into thyroid hormone replacement therapy.

Authors:  Brenda M Acosta; Antonio C Bianco
Journal:  F1000 Med Rep       Date:  2010-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.